0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global lysosomal storage diseases market size status forecast 2025.Your search for "" gave back 1533058 results.
The “Lysosomal Acid Lipase Deficiency (LALD) Treatment Industry Forecast” looks at past sales and reviews total world Lysosomal Acid Lipase...
Catalog:
LPI
March 2023
Price: USD 3,660.00
According to our publisher latest study, the global Lysosomal Storage Disorders market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The Sphingolipidoses are a group of inherited metabolic disorder caused due to deficiency of specific enzymes in the body. It is also known as...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
July 2022
Price: USD 2,000.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research’s latest report,...
Catalog:
CBR Pharma Insights
October 2018
Price: USD 2,995.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2018 Summary N...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021 Summary Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Lysosomal Storage Disorder Drugs...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
The global Metabolic Disorder Therapeutics market is projected to reach US$ 64560 million in 2029, increasing from US$ 46680 million in 2022, with...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H2 2020 Summary N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or...
Catalog:
Global Markets Direct
August 2020
Price: USD 3,500.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
